Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
16.24 USD | +34.55% | +48.45% | +45.00% |
02:11pm | B. Riley Raises Price Target on Harrow Health to $29 From $26, Keeps Buy Rating | MT |
05-14 | Transcript : Harrow, Inc., Q1 2024 Earnings Call, May 14, 2024 |
End-of-day quotes
Sector Other Pharmaceuticals
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
575M | - | - | - | |||
588B | ||||||
364B | ||||||
326B | ||||||
285B | ||||||
239B |
- Stock Market
- Equities
- HROW Stock
- Charts Harrow, Inc.
- Sector Chart